CRI Funded Scientists

Siva Karthik Varanasi, PhD, Postdoctoral Fellow

Salk Institute for Biological Studies

Area of Research: Liver Cancer

Our immune system constantly defends our body from threats, including cancer. Under circumstances that are not entirely known, cancer cells can develop ways to evade immune responses, which can result in their uncontrolled and malignant growth. A better understanding of how tumor cells suppress the function of immune cells, especially killer T cells, could lead to strategies with immense therapeutic potential.

Liver cancer is one tumor type where killer T cell responses often fail to control tumor growth. This may partially be due the accumulation of bile acids, which are produced at excess levels in liver tumors and appear to directly suppress the activity of killer T cells. In this proposal, Dr. Varanasi will characterize the mechanisms behind bile acid-mediated inhibition of killer T cells and investigate novel therapeutic interventions that regulate bile acid signaling in order to improve the effectiveness of immunotherapy for liver cancer.

Projects and Grants

Role of Bile Acid Signaling in CD8 T Cell Mediated Control of Hepatocellular Carcinoma

Salk Institute for Biological Studies | Liver Cancer | 2020 | Susan M. Kaech, PhD

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.